WHO ICTRP trial
BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in…
NL-OMON42096 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON42096 |
|---|---|
| Public title | BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in Patients 12 to 17 Years of Age |
| Scientific title | BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in Patients 12 to 17 Years of Age - BOTOX® for Paediatric Urinary Incontinence |
| Primary sponsor | Allergan Limited |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Australia;Belgium;Canada;Czechia;France;Germany;Hong Kong;Italy;Netherlands ;Norway;Poland;South Africa;Taiwan (Province of China);United Kingdom;United States of America |
| Conditions | Overactive Bladder urinary incontinence;10004994;Overactive Bladder;urinary incontinence |
| Interventions | Patients will initially be randomized on day 1 to one of 3 treatment groups in a 1:1:1 ratio: * 25 U BOTOX (not to exceed 6 U/kg) * 50 U BOTOX (not to exceed 6 U/kg) * 100 U BOTOX (not to exceed 6 U/kg) Patients will be centrally randomized… |
| Registration date | Jul 22, 2015 |
| Target size | 15 |
| Secondary IDs | 2014-000464-17;NCT02097121;NL50232.091.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: